The Actos Now for Prevention of Diabetes (ACT NOW) study showed beneficial effects of the insulin-sensitizing agent pioglitazone on carotid intima-media thickness in individuals with impaired glucose tolerance [19]. The gene discussed is INS; the disease is Impaired glucose tolerance.